β-Arrestin-2 modulates radiation-induced intestinal crypt progenitor/stem cell injury

Area of Science:

• Radiation oncology
• Gastroenterology
• Cell biology

Background:

• Ionizing radiation (IR) causes gastrointestinal syndrome via intestinal crypt progenitor/stem (ICPS) and vascular endothelial cell apoptosis.
• Signaling pathways for IR-induced ICPS cell apoptosis are not fully understood.
• Beta-arrestins (βArrs) are implicated as multifunctional adaptors in apoptosis.

Purpose of the Study:

• To investigate the role of beta-arrestin-2 (βarr2) in IR-induced ICPS cell apoptosis and intestinal injury.
• To elucidate the molecular mechanisms underlying βarr2-mediated ICPS cell apoptosis.
• To assess the potential of targeting the βarr2 pathway for radioprotection.

Main Methods:

• Utilized βarr2-deficient mice and in vitro cell cultures (Lgr5+ cells).
• Assessed ICPS and Lgr5+ cell apoptosis, crypt proliferation, and survival post-IR.
• Investigated the interaction of βarr2 with IκBα and its effect on NF-κB and PUMA signaling.

Main Results:

• βarr2 deficiency significantly decreased IR-induced ICPS and Lgr5+ stem cell apoptosis.
• βarr2-deficient mice showed enhanced crypt proliferation, improved survival, and radioresistance.
• Radioprotection in βarr2-deficient cells involved sustained NF-κB activation and suppressed PUMA induction.
• βarr2 deficiency had minimal impact on IR-induced vascular endothelial cell apoptosis.

Conclusions:

• βarr2-mediated ICPS cell apoptosis is critical for initiating and developing radiation-induced gastrointestinal syndrome.
• The βarr2/NF-κB/PUMA pathway is a novel target for radiomitigation in radiotherapy.
• Targeting βarr2 may reduce gastrointestinal damage during radiotherapy.